Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jan;5(4):134-7.
doi: 10.1007/BF02918288.

Determination of the platelet activating factor in silicotic patients and its effect on fibroblasts

Q Zhang  1 , Y Mo, J Lou, X Zhu, Z Chen, L He, H Zhong
Affiliations

Determination of the platelet activating factor in silicotic patients and its effect on fibroblasts

Q Zhang et al. Environ Health Prev Med. 2001 Jan.

Abstract

Platelet-activation factor (PAF), one of the potent proinflammatory mediators, is produced from a large range of cells, including polymorphonuclear neutrophils, monocytes, and natural killer cells. To study the role of PAF in the pathogenesis of silicosis, we determined the PAF in silicotic patients and in healthy persons. The results showed that the concentration of PAF in the plasma of silicotic patients was significantly higher than that of healthy persons. Ourin vitro experimental results showed that the total numbers of fibroblasts were markedly raised with added PAF from 0 to 1 μ g/ml. Adding 1 μ g/ml PAF significantly increased the total numbers of fibroblasts after culture for 48, 72, 96 hrs. Therefore, we suggest that PAF be possibly involved in the pathogenesis of silicosis. However, the mechanism remains to be further elucidated.

Keywords: Fibroblasts; Platelet activating factor (PAF); Silicosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1111/j.1365-2222.1992.tb00160.x', 'is_inner': False, 'url': 'https://doi.org/10.1111/j.1365-2222.1992.tb00160.x'}, {'type': 'PubMed', 'value': '1628249', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1628249/'}]}
    2. Spencer DA. Platelet activating factor (PAF). Clin Exp Allergy 1992; 22: 521–4. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1007/BF02536485', 'is_inner': False, 'url': 'https://doi.org/10.1007/bf02536485'}, {'type': 'PubMed', 'value': '1819750', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1819750/'}]}
    2. Nojima S. An update on PAF., Lipids 1991; 26: 965–6. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1854106', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1854106/'}, {'type': 'PubMed', 'value': '2850058', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/2850058/'}]}
    2. Stewart AG, Dusting GJ. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br J Pharmacol 1988; 94: 1225–33. - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1172/JCI112980', 'is_inner': False, 'url': 'https://doi.org/10.1172/jci112980'}, {'type': 'PMC', 'value': 'PMC424426', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC424426/'}, {'type': 'PubMed', 'value': '3553241', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/3553241/'}]}
    2. Chang SW, Fewderrsen CO, Henson PM, Voelkel NF. Platelet-activating factor mediates hemodynamic changes in lung injury in endotoxin-treated rats. J Clin Invest 1987; 79: 1498–509. - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2307/3430666', 'is_inner': False, 'url': 'https://doi.org/10.2307/3430666'}, {'type': 'PMC', 'value': 'PMC1568314', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1568314/'}, {'type': 'PubMed', 'value': '1696541', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1696541/'}]}
    2. Evans TW, McAnulty RJ, Rogers DF, Chung KF, Barnes PJ, Laurent GJ. Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion. Environ Health Persp. 1990; 85: 65–9. - PMC - PubMed